Well when the stock is at five bucks I guess a buck fifty will look cheap. I don't see the rsh this mornIng to jump the market but then again it cold just be someone wanting to secure shares in the open auction.
I have to wait a few more days will funds clear before I can buy more. I'm afraid I got caught with my pants down. Didn't expect such a strong first quarter from Inavir. I wonder if they have issued any guidance. All I can see is this quarter production expected at 4m doses. Perhaps worth around 3m to bta and much more for licensIng negotiations. Gee it would be nice if BTA and DS secured non dilutive fundIng for a ROW trial. I still don't see why the Japanese data and actual use cannot be used for FDA application. Seems like red tape for red tape sake.
BTA Price at posting:
$1.31 Sentiment: Buy Disclosure: Held
